Ayman joined Mubadala Capital in is a San Francisco-based investor at Mubadala Capital - Ventures. In his role, he focuses on early and growth stage investments in technology, healthcare, and life sciences. Prior to Mubadala, Ayman worked in corporate development at Tecan Group (SWX: Tecan) where he co-managed M&A and equity investment efforts in the US and Europe. He began his career as a management consultant at Accenture, where he helped businesses in Canada and the US solve critical strategy and operational challenges. He has also worked with the hedge fund team at OMERS Capital, where he focused on the intersection of machine learning and event-driven investing. In addition to his investing and consulting background, Ayman’s journey includes operating experience having been involved with a number of startups, including Sentinelle Medical (acquired by Hologics), Pullsar Technologies (acquired by Tecan), and Airo Health (Y Combinator, Summer 2016 batch). Ayman completed his M.B.A. and mechanical engineering studies at the University of Toronto where he received the Chalmers award and a fellowship for his engineering research thesis investigating novel Lab-on-a-Chip platforms.